NEW YORK (GenomeWeb) – Rainbow Genomics said today that it is partnering with Color to provide hereditary cancer and heart health genetic risk assessment tests in Hong Kong. Rainbow, a preferred partner of Color in Hong Kong, will offer that firm's genetic tests for the analysis of a patient's risk for eight hereditary cancers and four hereditary heart health conditions. The partnership, Rainbow said, will provide a fully integrated solution for actionable clinical test results at an affordable price point, though it did not elaborate.
Rainbow Genomics is to provide Californian firm Color Genomics ' genetic tests to consumers in Hong Kong , testing for four hereditary diseases and four hereditary heart health conditions . Given the company 's " chronic shortage " of genetic counsellors and prohibitive cost associated with such testing , Rainbow CEO Daniel Siu said the collaboration was a " significant step " towards enabling anyone to be tested for genetic risk to inherited conditions . The announcement follows Rainbow labs ' earlier announcement that it was looking to partner with US firms to offer genetic testing in Asia .